World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT01562964
Date of registration: 22/03/2012
Prospective Registration: No
Primary sponsor: Imperial College London
Public title: Hypnotherapy in Patients With Chest Pain & Unobstructed Coronaries
Scientific title: The Impact of Hypnotherapy on Symptoms, Psychological Morbidity and Quality of Life in Postmenopausal Women With Chest Pain and Unobstructed Coronary Arteries
Date of first enrolment: February 1, 2012
Target sample size: 0
Recruitment status: Withdrawn
URL:  https://clinicaltrials.gov/show/NCT01562964
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
United Kingdom
Contacts
Name:     Peter Collins, MD, FRCP
Address: 
Telephone:
Email:
Affiliation:  Imperial College London, and Royal Brompton & Harefield NHS Foundation Trust
Key inclusion & exclusion criteria

Inclusion Criteria:

- history of chest pain for = 2 years

- = 2 episodes chest pain per week

- angiographically smooth epicardial coronary arteries

- Willing to give written informed consent

Exclusion Criteria:

- Any epicardial coronary atheroma on angiography of the coronary arteries

- left ventricular hypertrophy or dysfunction (clinical/ECG/echo/CXR)

- previous hypnotherapy for chest pain symptoms

- participation in research project within previous 60 days

- unwilling to give written informed consent



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Chest Pain
Unobstructed Coronary Arteries
Intervention(s)
Behavioral: Supportive therapy
Behavioral: Hypnotherapy
Primary Outcome(s)
Symptom frequency [Time Frame: 24 weeks]
Secondary Outcome(s)
Hospitalisations [Time Frame: 24 weeks]
Consultancy time [Time Frame: 24 weeks]
General quality of life [Time Frame: 24 weeks]
Medication use [Time Frame: 24 weeks]
Symptom severity [Time Frame: 24 weeks]
Psychological morbidity [Time Frame: 24 weeks]
Secondary ID(s)
P40285
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history